These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 24308974)

  • 1. Rapid evolution of binding specificities and expression patterns of inhibitory CD33-related Siglecs in primates.
    Padler-Karavani V; Hurtado-Ziola N; Chang YC; Sonnenburg JL; Ronaghy A; Yu H; Verhagen A; Nizet V; Chen X; Varki N; Varki A; Angata T
    FASEB J; 2014 Mar; 28(3):1280-93. PubMed ID: 24308974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation?
    Cao H; Crocker PR
    Immunology; 2011 Jan; 132(1):18-26. PubMed ID: 21070233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large-scale sequencing of the CD33-related Siglec gene cluster in five mammalian species reveals rapid evolution by multiple mechanisms.
    Angata T; Margulies EH; Green ED; Varki A
    Proc Natl Acad Sci U S A; 2004 Sep; 101(36):13251-6. PubMed ID: 15331780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning, characterization, and phylogenetic analysis of siglec-9, a new member of the CD33-related group of siglecs. Evidence for co-evolution with sialic acid synthesis pathways.
    Angata T; Varki A
    J Biol Chem; 2000 Jul; 275(29):22127-35. PubMed ID: 10801860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sialic acid-binding immunoglobulin-like lectins (Siglecs) detect self-associated molecular patterns to regulate immune responses.
    Läubli H; Varki A
    Cell Mol Life Sci; 2020 Feb; 77(4):593-605. PubMed ID: 31485715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery, classification, evolution and diversity of Siglecs.
    Angata T; Varki A
    Mol Aspects Med; 2023 Apr; 90():101117. PubMed ID: 35989204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Siglecs at the Host-Pathogen Interface.
    Chang YC; Nizet V
    Adv Exp Med Biol; 2020; 1204():197-214. PubMed ID: 32152948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene conversions are frequent but not under positive selection in the Siglec gene families of primates.
    Zid M; Drouin G
    Genome; 2014 Jun; 57(6):317-25. PubMed ID: 25166301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative genomics indicates the mammalian CD33rSiglec locus evolved by an ancient large-scale inverse duplication and suggests all Siglecs share a common ancestral region.
    Cao H; de Bono B; Belov K; Wong ES; Trowsdale J; Barrow AD
    Immunogenetics; 2009 May; 61(5):401-17. PubMed ID: 19337729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and expression of 3 siglecs-like in Oreochromis niloticus neutrophil, and their interaction with group B streptococcal sialylated capsular polysaccharides.
    Dong J; Wei Y; Ye X; Sun C; Tian Y; Lu M; Du J; Chen Z
    Mol Immunol; 2016 May; 73():158-69. PubMed ID: 26847490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells.
    Avril T; Floyd H; Lopez F; Vivier E; Crocker PR
    J Immunol; 2004 Dec; 173(11):6841-9. PubMed ID: 15557178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning and characterization of a novel mouse Siglec, mSiglec-F: differential evolution of the mouse and human (CD33) Siglec-3-related gene clusters.
    Angata T; Hingorani R; Varki NM; Varki A
    J Biol Chem; 2001 Nov; 276(48):45128-36. PubMed ID: 11579105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Siglecs: A journey through the evolution of sialic acid-binding immunoglobulin-type lectins.
    Bornhöfft KF; Goldammer T; Rebl A; Galuska SP
    Dev Comp Immunol; 2018 Sep; 86():219-231. PubMed ID: 29751010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interplay between Siglecs and sialylated pathogens.
    Chang YC; Nizet V
    Glycobiology; 2014 Sep; 24(9):818-25. PubMed ID: 24996821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sialoglycans and Siglecs Can Shape the Tumor Immune Microenvironment.
    van de Wall S; Santegoets KCM; van Houtum EJH; Büll C; Adema GJ
    Trends Immunol; 2020 Apr; 41(4):274-285. PubMed ID: 32139317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host and pathogen hyaluronan signal through human siglec-9 to suppress neutrophil activation.
    Secundino I; Lizcano A; Roupé KM; Wang X; Cole JN; Olson J; Ali SR; Dahesh S; Amayreh LK; Henningham A; Varki A; Nizet V
    J Mol Med (Berl); 2016 Feb; 94(2):219-33. PubMed ID: 26411873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible Influences of Endogenous and Exogenous Ligands on the Evolution of Human Siglecs.
    Angata T
    Front Immunol; 2018; 9():2885. PubMed ID: 30564250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Siglec-7: a sialic acid-binding lectin of the immunoglobulin superfamily.
    Angata T; Varki A
    Glycobiology; 2000 Apr; 10(4):431-8. PubMed ID: 10764831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression profiling of immune inhibitory Siglecs and their ligands in patients with glioma.
    Santegoets KCM; Gielen PR; Büll C; Schulte BM; Kers-Rebel ED; Küsters B; Bossman SAJFH; Ter Laan M; Wesseling P; Adema GJ
    Cancer Immunol Immunother; 2019 Jun; 68(6):937-949. PubMed ID: 30953118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensing the neuronal glycocalyx by glial sialic acid binding immunoglobulin-like lectins.
    Linnartz-Gerlach B; Mathews M; Neumann H
    Neuroscience; 2014 Sep; 275():113-24. PubMed ID: 24924144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.